Pila Pharma
Pre-clinicalPila Pharma AB is a clinical stage biotech company developing a potent, selective TRPV1 antagonist, XEN-D0501, as treatment of type 2 diabetes and the rare painful disease erythromelalgia.
Founded
2015
Focus
Small Molecules
About
Pila Pharma AB is a clinical stage biotech company developing a potent, selective TRPV1 antagonist, XEN-D0501, as treatment of type 2 diabetes and the rare painful disease erythromelalgia.
Funding History
2Total raised: $5.7M
Series A$4.5MUndisclosedJun 15, 2019
Seed$1.2MUndisclosedJun 15, 2016
Company Info
TypePrivate
Founded2015
LocationMalmö, Sweden
StagePre-clinical
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile